跳至主要内容
临床试验/NCT04228055
NCT04228055Unknown不适用

Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)

University of Arizona4 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2020年8月7日最近更新:
适应症

试验速览

阶段
不适用
入组人数
36
试验地点
4
主要终点
Retention of Participants

研究概览

简要总结

This study is an investigator initiated clinical study. A prospective, single arm unblinded, open label study will be carried out to determine the feasibility of recruitment, retention and adherence of 36 prostate cancer survivors who have been on androgen deprivation therapy within the last 5 years for a lifestyle modification intervention.

详细描述

INTRODUCTION:

Androgen deprivation therapy (ADT) has been demonstrated to improve disease free and over-all survival in men with prostate cancer (PCa).

ADT for PCa is associated with adverse cardio-metabolic effects such as reduced libido, hot flashes, metabolic syndrome, diabetes, myocardial infarction and stroke. This reduces quality of life (QoL) and potentially affects mortality.

There is paucity of data regarding comprehensive lifestyle interventions in men on ADT for Pca. Existing studies used non-standardized interventions or lack data on metabolic risk factors.

CLIPP is designed to address these gaps by using an intervention modelled after the Diabetes Prevention Program (DPP) with an emphasis on low carbohydrate and a Keto Diet, a standardized multi-component intervention with demonstrated effectiveness in reducing diabetes risk factors that has been successfully adapted for multiple disease types including breast cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Diagnosed with prostate cancer Stage I, II or III
  • On androgen deprivation therapy with last 5 years
  • Willing to participate in a lifestyle modification program
  • Willing to modify diet and eating practices
  • Willing to participate in blood collection, urine collection and measurements
  • Minimum of 30 days since participating in another study/trial
  • English speaking
  • 40 to 80 years of age
  • BMI >25%

排除标准

  • Currently participating in another study or trial
  • Currently in hospice
  • Inability to walk two city blocks
  • Inability to comprehend informed consent or procedural requirements
  • Digestive Diseases (IBD, Diverticulitis, etc) that might prevent him from increasing fruit and vegetable intake
  • Subjects already following an intensive lifestyle modification plan
  • BMI <25%

结局指标

主要结局

Retention of Participants

时间窗: 6 Months

75% retention rate

Adherence to Intervention

时间窗: 6 Months

75% attendance rate throughout 24 intervention visits

Reach Recruiting Target

时间窗: 6 Months

Recruit 36 men with prostate cancer who have been on androgen deprivation therapy within the last 5 years.

次要结局

  • Lipid Panel(6 Months)
  • Fasting Glucose(6 Months)
  • Hemoglobin A1c(6 Months)
  • CBC(6 Months)
  • Global Quality of Life Questionnaire(6 Months)
  • Specific Quality of Life Questionnaire(6 Months)
  • CMP(6 Months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验